Major Travel, Real Estate, Media Players Rely on Cordial’s AI to Win Customer Attention, Revenue
Industry Leaders BuzzFeed, HuffPost, Virgin Voyages, and Realtor.com® Transform Customer Experiences with Cordial SAN DIEGO, May 29, 2025 /PRNewswire/ — Cordial,... Read more.
Neema Unveils Dynamic Routing, Ensuring Seamless Transaction Flow and Optimization of Every Cross-Border Transaction for FX Rates, Efficiency and Speed
TEL AVIV, Israel, May 29, 2025 /PRNewswire/ — Neema, a pioneering global cross-border payments network catering to financial institutions, launched today Dynamic... Read more.
Diakonos Oncology to Present Phase I Results of Dubodencel (DOC1021), a Double-Loaded Dendritic Cell Therapy for Glioblastoma, at the ASCO 2025 Annual Meeting
HOUSTON, May 29, 2025 /PRNewswire/ — Diakonos Oncology Corp., a clinical-stage biotechnology company developing a new generation of immunotherapies to treat... Read more.
Buildots Raises $45 Million to Scale AI-Powered Operational Excellence in Construction
Investment brings total funding to $166M; will accelerate construction industry transformation amid booming mega-project construction TEL AVIV, Israel, May 29, 2025... Read more.
Neuronata-R® Stem Cell Therapy Shows Promise in ALS Phase 3 Subgroup Analysis, Moves Toward FDA Accelerated Approval
Meaningful efficacy observed in slow-progressor subgroup; NfL biomarker improvements support potential for accelerated regulatory pathway SEOUL, South Korea, May... Read more.
AccurEdit Therapeutics’ ART001 Becomes China’s First Gene Editing Therapy to Receive FDA Regenerative Medicine Advanced Therapy (RMAT) Designation
RMAT designation expected to expedite development; 72 weeks interim clinical trial data showing sustainable reduction of TTR over 90% with no significant adverse... Read more.
NeuLogiq® Platform Confirms Electrophysiological Marker of Target Engagement in Patients with Major Depressive Disorder
Data presented by Delix Therapeutics at the 2025 American Society of Clinical Psychopharmacology (ASCP) Conference confirms the NeuLogiq® Platform is effective... Read more.
Rain Expands Support to Solana, Tron, and Stellar, Enabling More Partners to Launch Stablecoin-powered Card Programs
New integrations expand Rain’s multi-chain support, enabling partners to easily launch stablecoin-powered card programs across even more blockchains simultaneously... Read more.
Rona Therapeutics Announces Breakthrough Data on Potential Annual Dosing RNAi Therapy RN026 Targeting Lipoprotein(a) in The National Lipid Association (NLA) Scientific Sessions 2025
SHANGHAI, May 29, 2025 /PRNewswire/ — Rona Therapeutics, a global leading RNA therapy company, today announced preclinical data for its self-developed RNA... Read more.
CODIT Launches ‘APEC 2025’ Policy Monitoring Platform
AI-Powered Legislative Insights: CODIT’s Global Evidence-Based Policy Institute strengthens policy research and strategy SEOUL, South Korea, May 29, 2025 /PRNewswire/... Read more.